TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3884697

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg parenterally
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg orally
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Open-labeled metoclopramide
Number of subjects: 13
Study: 3371390

Group type: EXPERIMENTAL
Intervention: Metoprolol CR 100 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoprolol CR 200 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29802818

Group type: EXPERIMENTAL
Intervention: MGV354 (0.1%)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 66
Study: 28207976

Group type: EXPERIMENTAL
Intervention: Increased physical activity in school (2×45 minutes physically active academic lessons, 5×10 minutes physically active breaks, and 5×10 minutes physically active homework)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Control group (no increased physical activity)
Number of subjects: 449
Study: 25475519

Group type: EXPERIMENTAL
Intervention: Simulation-based curriculum
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control cohort (full immersion environment)
Number of subjects: 32
Study: 23987198

Group type: EXPERIMENTAL
Intervention: C1 esterase inhibitor (C1‐INH) concentrate 20 U/kg within <6 hours after start of an attack
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: C1 esterase inhibitor (C1‐INH) concentrate 20 U/kg after ≥6 hours after start of an attack
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: C1 esterase inhibitor (C1‐INH) concentrate
Number of subjects: 2
Study: 21917874

Group type: EXPERIMENTAL
Intervention: Fasting while receiving placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fasting while receiving metreleptin in physiological replacement doses
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Physiological or pharmacological metreleptin doses (0.01, 0.1, or 0.3 mg/kg i.v. four times daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Isocaloric diet
Number of subjects: 11
Study: 18210955

Group type: EXPERIMENTAL
Intervention: Topical negative pressure (TNP)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 3
Study: 16990078

Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/d
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study: 12945135

Group type: EXPERIMENTAL
Intervention: Laser radiation treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Imitation of laser radiation
Number of subjects: 93
Study: 10862446

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg to 300 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Enalapril 10 mg to 20 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 116
Study: 9125262

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8468436

Group type: EXPERIMENTAL
Intervention: moclobemide
Number of subjects: 237

Group type: COMPARATOR
Intervention: doxepin
Number of subjects: 237
Study: 3709379

Group type: EXPERIMENTAL
Intervention: Caloric restricted diet (300 kcal/d) over 4 weeks + ergometer exercise programme (up to 2 hours daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Caloric restricted diet (300 kcal/d) over 4 weeks
Number of subjects: 20
Study: 30329096

Group type: EXPERIMENTAL
Intervention: Diet with 0.515% Valine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.585% Valine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.655% Valine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.725% Valine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.795% Valine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet with 0.865% Valine
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Valine requirement estimated by linear broken line model
Number of subjects: 270
Study: 29554188

Group type: EXPERIMENTAL
Intervention: Forbrain group (device turned on during the test phase)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (device kept off during the test phase)
Number of subjects: 0
Study: 27273602

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention
Number of subjects: 1612

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1612
Study: 25583399

Group type: EXPERIMENTAL
Intervention: VE+US group
Number of subjects: 1903

Group type: COMPARATOR
Intervention: VE group
Number of subjects: 1903
Study: 23937731

Group type: EXPERIMENTAL
Intervention: Pilates-based exercise (n = 40)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (n = 34)
Number of subjects: 74
Study: 20716304

Group type: EXPERIMENTAL
Intervention: Co-occurring psychiatric symptoms (mood symptoms, anxiety symptoms, suicidal thinking)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Co-occurring psychiatric symptoms
Number of subjects: 174
Study: 18334500

Group type: EXPERIMENTAL
Intervention: Multiple regression model including treatment and covariates
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Propensity score method
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Ecologic approach using grouped treatment variable
Number of subjects: 720
Study: 16564644

Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 14524508

Group type: EXPERIMENTAL
Intervention: Modified neuromuscular electrical stimulation (NMES) training program
Number of subjects: 43

Group type: COMPARATOR
Intervention: Comparison group (no NMES treatment)
Number of subjects: 43
Study: 11017984

Group type: EXPERIMENTAL
Intervention: Positive physician communication behaviors
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Severe medical outcome
Number of subjects: 104
Study: 9352394

Group type: EXPERIMENTAL
Intervention: 0, 12.5, 25, 50, and 100 mg triamterene
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0, 25, and 50 mg triamterene with 12.5 and 25 mg hydrochlorothiazide
Number of subjects: 22
Study: 8250349

Group type: EXPERIMENTAL
Intervention: Paragerm AK
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 33
Study: 3940620

Group type: EXPERIMENTAL
Intervention: Trioxifene mesylate (5 mg, 10 mg, 20 mg orally twice daily)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Trioxifene mesylate after tamoxifen failure
Number of subjects: 69

Group type: COMPARATOR
Intervention: Tamoxifen (previous treatment)
Number of subjects: 69
Study: 30046738

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) administered twice daily for 3 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care (SOC) including unfractionated heparin (UFH) or low‐molecular‐weight heparin (LMWH) for 3 months
Number of subjects: 180
Study: 27506164

Group type: EXPERIMENTAL
Intervention: Intervention in Home Care to Improve Health Outcomes (In‐Home)
Number of subjects: 22
Study: 26161388

Group type: COMPARATOR
Intervention: Glidescope (GS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pentax‐AWS Airwayscope (AWS)
Number of subjects: 24
Study: 23364126

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard of Care Wait List (SOC/WL)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: EFT (after SOC/WL wait period)
Number of subjects: 59
Study: 21176326

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (GTN)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 18854728

Group type: EXPERIMENTAL
Intervention: 0.1% brimonidine Purite (BP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.15% brimonidine Purite (BP)
Number of subjects: 22
Study: 16054779

Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarettes
Number of subjects: 15

Group type: COMPARATOR
Intervention: De-nicotinized cigarettes
Number of subjects: 15
Study: 12547742

Group type: EXPERIMENTAL
Intervention: Glucosamine (2,000 mg per day for 12 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 46
Study: 10819406

Group type: EXPERIMENTAL
Intervention: eptifibatide
Number of subjects: 258

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: eptifibatide and placebo
Number of subjects: 258
Study: 8740466

Group type: EXPERIMENTAL
Intervention: Experimental hostility-reduction treatment group
Number of subjects: 22

Group type: COMPARATOR
Intervention: Information-control group
Number of subjects: 22
Study: 1661216

Group type: EXPERIMENTAL
Intervention: Intense exercise (90% VO2max)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Mild exercise (20% VO2max)
Number of subjects: 6
Study: 7072622

Group type: EXPERIMENTAL
Intervention: 1 g beta‐sitosterol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2 g beta‐sitosteryl oleate
Number of subjects: 9

Group type: COMPARATOR
Intervention: No additive
Number of subjects: 9
Study: 31167663

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 35
Study: 26375868

Group type: EXPERIMENTAL
Intervention: Reading aloud exercises (3 times per day for 4 weeks, increasing from 5 to 20 minutes)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no reading aloud exercises)
Number of subjects: 62
Study: 26511218

Group type: EXPERIMENTAL
Intervention: Postoperative low-level laser therapy (LLLT) treatment for 21 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group without postoperative laser treatment
Number of subjects: 30
Study: 23169523

Group type: EXPERIMENTAL
Intervention: Parenteral hydration (normal saline 1 L per day)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo (normal saline 100 mL per day)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Parenteral hydration
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 21114535

Group type: EXPERIMENTAL
Intervention: YSPSL (recombinant P-selectin glycoprotein ligand Ig) administered systemically to the recipient pre-reperfusion.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no YSPSL treatment).
Number of subjects: 40
Study: 20133269

Group type: EXPERIMENTAL
Intervention: Initial antiretroviral therapy with resistance mutations at baseline
Number of subjects: 781

Group type: COMPARATOR
Intervention: Initial antiretroviral therapy without resistance mutations at baseline
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Presence of resistance mutations at baseline
Number of subjects: 781

Group type: COMPARATOR
Intervention: Absence of resistance mutations at baseline
Number of subjects: 781
Study: 17106317

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring (24-h noninvasive)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Clinic blood pressure monitoring
Number of subjects: 292
Study: 15559222

Group type: EXPERIMENTAL
Intervention: Cerebrolysin 10 ml/d
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cerebrolysin 50 ml/d
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 11352694

Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg/d
Number of subjects: 3514
Study: 7566576

Group type: EXPERIMENTAL
Intervention: Perindopril (2 mg/day per os)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 10
Study: 2132299

Group type: EXPERIMENTAL
Intervention: Keto acids treatment for 12 months
Number of subjects: 40
Study: 377154

Group type: EXPERIMENTAL
Intervention: Sulindac 200mg b.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen 400mg t.d.s.
Number of subjects: 0
Study: 31469938

Group type: EXPERIMENTAL
Intervention: Inhibitory control training (IC) using Color-Word Stroop and Stop-Signal tasks
Number of subjects: 123

Group type: COMPARATOR
Intervention: Active control (AC) using knowledge- and vocabulary-based tasks
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Inhibitory control training (IC)
Number of subjects: 123
Study: 30630671

Group type: EXPERIMENTAL
Intervention: 62.5 mg acetazolamide twice daily
Number of subjects: 73

Group type: COMPARATOR
Intervention: 125 mg acetazolamide twice daily
Number of subjects: 73
Study: 28072446

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg administered intravenously 30 minutes before surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexamethasone and Placebo
Number of subjects: 120
Study: 25527168

Group type: EXPERIMENTAL
Intervention: Preoperative dextromethorphan and preoperative intercostal block (IB)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Preoperative placebo and preoperative intercostal block (IB)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Preoperative dextromethorphan and postoperative intercostal block (IB)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Preoperative placebo and postoperative intercostal block (IB)
Number of subjects: 400
Study: 24461279

Group type: EXPERIMENTAL
Intervention: Preoperative incentive spirometry education (POISE)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 140
Study: 22847248

Group type: EXPERIMENTAL
Intervention: Cataract extraction and intraocular lens insertion after intraocular pressure lowering
Number of subjects: 10
Study: 20704622

Group type: EXPERIMENTAL
Intervention: Rituximab (1000 mg courses, two doses with a 15-day interval)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cytotoxic combination therapy (pulse cyclophosphamide 1000 mg/monthly, azathioprine 2-3 mg/kg per day, and prednisolone 0.5 mg/kg per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cytotoxic combination therapy
Number of subjects: 20
Study: 17656069

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Resistant starch
Number of subjects: 31

Group type: COMPARATOR
Intervention: Chronic soy intake
Number of subjects: 31
Study: 16295703

Group type: EXPERIMENTAL
Intervention: Quit and Win contest (30-day quit period, provider advice via weekly mailings, online and telephone quit assistance, media campaign, community support)
Number of subjects: 1006

Group type: COMPARATOR
Intervention: Control group (randomly selected tobacco users not exposed to the promotional media campaign)
Number of subjects: 1006
Study: 12815798

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (7 mmHg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (12 mmHg)
Number of subjects: 20
Study: 9255754

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily for 1 year
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 40
Study: 8123097

Group type: EXPERIMENTAL
Intervention: Educational outreach intervention by a transfusion specialist including a lecture and a 30-minute visit with each physician.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (surgeons not receiving the educational intervention).
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Educational outreach intervention.
Number of subjects: 101
Study: 3830248

Group type: EXPERIMENTAL
Intervention: 100 mg indomethacin suppository administered at 9.00 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg indomethacin suppository administered at 21.00 hours
Number of subjects: 12
Study: 30209962

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg/h)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (Continuous propofol infusion and fentanyl boluses)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 µg/kg/h)
Number of subjects: 59
Study: 27428384

Group type: EXPERIMENTAL
Intervention: Chlorhexidine bathing every other day
Number of subjects: 325

Group type: COMPARATOR
Intervention: Soap and water bathing daily
Number of subjects: 325
Study: 24829910

Group type: EXPERIMENTAL
Intervention: Ghostman (augmented reality application)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Face-to-face instruction
Number of subjects: 0
Study: 22183877

Group type: COMPARATOR
Intervention: Detrusor wall thickness (DWT) measured when bladder is full (DWT-1)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Detrusor wall thickness (DWT) measured when bladder is empty (DWT-2)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Postvoid residual urine volume (PVR)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Bladder and prostate volumes
Number of subjects: 243

Group type: COMPARATOR
Intervention: International Prostate Symptom Score (IPSS) correlation
Number of subjects: 243
Study: 20097107

Group type: EXPERIMENTAL
Intervention: Modified lateral orbitotomy approach
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modified hemicoronal approach
Number of subjects: 20
Study: 16206355

Group type: EXPERIMENTAL
Intervention: Milnacipran twice daily
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Milnacipran once daily
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 12076027

Group type: EXPERIMENTAL
Intervention: Probiotic (Enterococcus faecium)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Probiotic (Enterococcus faecium) + Vancomycin
Number of subjects: 20
Study: 10430726

Group type: EXPERIMENTAL
Intervention: 500 micrograms of nebulized ipratropium bromide (IB)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 29
Study: 7575711

Group type: EXPERIMENTAL
Intervention: CAMPATH-1H (C1H) 0.3 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CAMPATH-1H (C1H) 1.0 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CAMPATH-1H (C1H) 3.0 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CAMPATH-1H (C1H) 10.0 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CAMPATH-1H (C1H) 30.0 mg/day
Number of subjects: 30
Study: 2015144

Group type: EXPERIMENTAL
Intervention: Warmed group (maintained at normothermia during anaesthesia and surgery, nursed in a warm room for 24 h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cold group (received routine intraoperative and postoperative care)
Number of subjects: 16
Study: 6951838

Group type: EXPERIMENTAL
Intervention: Chlorhexidine evening rinse
Number of subjects: 18

Group type: COMPARATOR
Intervention: Chlorhexidine morning rinse
Number of subjects: 18
Study: 30282096

Group type: EXPERIMENTAL
Intervention: Unicortical tibial fixation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Bicortical tibial fixation
Number of subjects: 8

Group type: COMPARATOR
Intervention: PCL-deficient knees
Number of subjects: 8

Group type: COMPARATOR
Intervention: PCL-intact knees
Number of subjects: 8
Study: 30336824

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly
Number of subjects: 968

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study: 26749079

Group type: EXPERIMENTAL
Intervention: 0.5 mg intravitreal ranibizumab for three to 14 days before Ahmed glaucoma valve implantation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ahmed glaucoma valve implantation alone
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 43
Study: 23139071

Group type: EXPERIMENTAL
Intervention: Adjunctive photodynamic therapy using LED light (Fotosan) with toluidine blue O solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing (control)
Number of subjects: 30
Study: 22197412

Group type: EXPERIMENTAL
Intervention: 0.3% triclosan toothpaste
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 132
Study: 17556431

Group type: COMPARATOR
Intervention: SSRI and routine care
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: SSRI, routine care, and CBT
Number of subjects: 208
Study: 15134608

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) using the Dornier Epos Ultra, single therapy session
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sham treatment (Control Group)
Number of subjects: 150
Study: 11586670

Group type: EXPERIMENTAL
Intervention: Trandolapril (ACE inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9532417

Group type: EXPERIMENTAL
Intervention: Sound (90 dB, 1 kHz for 30s)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cooling
Number of subjects: 90
Study: 8083130

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (7 Gy single fraction administered < 4 h before surgery)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Postoperative radiotherapy (5 fractions of 3.5 Gy, total dose 17.5 Gy administered < 72 h after surgery)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Postoperative radiotherapy
Number of subjects: 84
Study: 2511802

Group type: EXPERIMENTAL
Intervention: Fleroxacin 400 mg once daily for 7 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Fleroxacin 600 mg once daily for 7 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Fleroxacin 800 mg once daily for 7 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Fleroxacin (600 or 800 mg) once daily for 7 days
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Fleroxacin
Number of subjects: 79
Study: 765518

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (trimethoprim, 10 mg; sulfamethoxazole, 50 mg/kg/day in divided doses every 12 hours)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ampicillin (100 mg/kg/day administered in divided doses every six hours)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 28
Study: 31284617

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) algorithm for LST retrieval from AMSR2 data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison with ground measurement data from meteorological stations
Number of subjects: 0
Study: 28433454

Group type: EXPERIMENTAL
Intervention: nTTT
Number of subjects: 42

Group type: COMPARATOR
Intervention: TFT
Number of subjects: 42

Group type: COMPARATOR
Intervention: TTHT
Number of subjects: 42